Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novo Nordisk A/S
  6. News
  7. MarketScreener Strategies
    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
Real-time Estimate Cboe Europe  -  03:44 2022-07-05 am EDT
793.90 DKK   -0.24%
07/04NOVO NORDISK A/S : Share repurchase programme
GL
06/30NOVO NORDISK A/S : The technical configuration is positive
06/29European ADRs Move Slightly Higher in Wednesday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Analysis
Investing in stability
The number of different investment strategies is probably equal to the number of investors. There are those who look for the rare gem that will make +30% over the next month, those who follow...
More Must read
Stock Pick
Novo Nordisk AS : Global leader in diabetes treatments
Novo Nordisk is the world leader in diabetes treatments and a long-standing rival of Sanofi. The company has successfully negotiated the repositioning of its portfolio.
More Recommendations
Stock Trading Strategies
NOVO NORDISK A/S - 06/30
The technical configuration is positive
BUY
NOVO NORDISK A/S - 03/08
Good timing to anticipate a continuation of the trend
BUY
NOVO NORDISK A/S - 2021
No turn-around in sight
BUY
More Stock Trading Analysis
Official Publications
04/29Press Release 
04/291st quarter report 
03/24Proxy Statments 
02/21Mixed general shareholder meeting 
02/02Annual Report 
02/02Press Release 
Upcoming event on NOVO NORDISK A/S
08/04/22Interim 2022 Earnings Release
Upcoming sector events
07/19/22JOHNSON & JOHNSON : Interim 2022 Earnings Release
07/21/22ROCHE HOLDING AG : Interim 2022 Earnings Release
07/28/22PFIZER INC. : Interim 2022 Earnings Release
07/29/22ABBVIE INC. : Interim 2022 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals